Moderna is opening a location in Basel and is advancing the production of the coronavirus vaccine from there. The Swiss government has just signed a supply contract with the US company for 4.5 million doses of the vaccine.
Read More
The Japanese conglomerate Yokogawa has established a Swiss subsidiary based at the Switzerland Innovation Park Basel Area. Here, the focus will be on driving forward innovation in the field of biotechnology.
Read More
Versant Ventures has made a US$35 million Series A funding commitment to Bright Peak Therapeutics and has now announced the debut of this biotech. It will operate in Basel and San Diego.
Read More
The Werner Siemens Foundation is to invest an additional 12 million Swiss francs in the Miracle project. Researchers at the University of Basel are developing visionary technology for the use of robots in surgery within the framework of this project.
Read More
T3 Pharmaceuticals AG has closed its third financing round, raising over 25 million Swiss francs. The Basel-based startup has developed a bacterial cancer therapy that it now intends to progress to clinical trials.
Read More
The Basel-based biopharmaceutical company Versameb has successfully closed a seed financing round. Versameb develops therapies on the basis of mRNA sequences and is now seeking to drive forward the clinical development of its platform devised for this.
Read More
Genedata, a Basel IT company specializing in the life sciences sector, has agreed a collaboration with Thermo Fisher. The integration of their two platforms will help accelerate the development of drugs.
Read More
Two thirds of the value added attributable to the pharmaceutical industry as a whole in Switzerland is generated in the Basel Area, as revealed by an Interpharma report. However, the region also shines in an international comparison. Interpharma CEO René Buholzer regards it as “probably the most productive life sciences location in the world”.
Read More
The cantons of Basel-Landschaft, Basel-Stadt and Jura have just published their first joint Economic Report. The fundamental environment is described as “good” in the report.
Read More
Resistell AG, based in Muttenz in the canton of Basel-Landschaft, has received a grant of up to 2.5 million euros and additional equity capital financing from a European fund with the aim of accelerating innovation. The company is developing the world’s fastest test against antibiotic resistance.
Read More
We are happy to present our latest addition to the Switzerland Innovation Park Basel Area: Our site on the Novartis Campus dedicated to digital health provides a focal point to a unique community of digital healthcare experts.
Read More
Two institutes from the University of Basel and a pharmaceutical company are relocating to the GRID innovation campus, which is currently under construction at BaseLink in Allschwil. The new building will also contain the headquarters of the Switzerland Innovation Park Basel Area in future.
Read More
Artidis, a startup from Basel, has developed a nanotechnology platform that can be used for cancer diagnosis, among other things. The platform has now been tested in a study that was able to achieve its primary endpoint.
Read More
Startup Academy is on the road to success ten years after being founded. The initiative has supported 280 startups to date. The project was originally started in Basel and is now represented at several locations in Switzerland with plans for further growth.
Read More
Syngenta AG, Adama and Sinochem are to be united under the umbrella of the new Syngenta Group. The group is headquartered in Basel and employs around 48,000 staff across over 100 countries.
Read More
The Muttenz-based biotechnology company Tolremo Therapeutics has raised an additional 4.7 million Swiss francs as part of a financing round. The company develops cancer therapies for precision medicine and is now driving forward clinical development.
Read More
The American health authority has granted Polyneuron’s drug PN-1007 orphan designation. This status uses special conditions to balance out commercial disadvantages when developing drugs for rare diseases.
Read More
BaseLaunch helps build therapeutic ventures to the point where they can raise a Series-A financing round or similar.
Read More
The i4Challenge is an acceleration program for SME, startups and new projects focused on innovative solutions, new approaches and next-generation products or services for Industry 4.0.
Read More
Ricola has been voted the most trustworthy brand in Switzerland. The manufacturer of herbal candy, which is based in the Basel Area, previously won this award in 2017.
Read More
The canton of Basel-Stadt accounts for 26 percent of Swiss exports. The pharma and chemical industries have above all contributed to this result. In per capita terms, Basel-Stadt exports goods totaling 316,855 Swiss francs. In the BaselArea as a whole, which includes Basel-Landschaft and Jura, the equivalent figure stands at 148,811 Swiss francs per capita.
Read More
A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health based in Basel is contributing the smartphone app for the project.
Read More
The Basel-based biopharmaceutical company Celonic Group has agreed a partnership with Airway Therapeutics from the USA. Together, the two companies are planning to develop a drug to treat coronavirus.
Read More
The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..
Read More
Humard has developed a robot that can disinfect spaces using UV light. For this, the system manufacturer from the canton of Jura has adapted a mobile industrial robot that is otherwise used in warehouse logistics.
Read More
Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.
Read More
The investment and innovation promotion agency Basel Area Business & Innovation, previously known as BaselArea.swiss, can look back on a successful year in 2019. In this regard, positive developments in the healthtech sector and in Switzerland Innovation Park Basel Area stand out.
Read More
Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.
Read More
The online program Selfapy supports people suffering from mental health conditions during the coronavirus lockdown. BaselArea.swiss has provided startup help by way of its DayOne initiative.
Read More
The University Hospital Basel is the first Swiss hospital to have treated two Covid-19 patients with the plasma from a patient who has recovered from the virus, which means that they are receiving the appropriate antibodies. This method is a potential therapeutic option.
Read More
The Basel-based Botnar Research Center for Child Health is providing capital in the amount of 15 million Swiss francs to its four partner institutions. In this way, the University of Basel should be in a position to advance research into dealing with the coronavirus outbreak.
Read More
In the fight against the coronavirus, Vas Narasimhan, CEO of Novartis, is above all pinning his hopes on a malaria drug. Narasimhan has claimed in an interview that this drug has proven in preclinical and initial clinical trials that it can destroy the virus. At the moment, patients are being enrolled for studies.
Read More
Basel/Liestal/Delémont – Because of the coronavirus crisis.the three sponsor cantons of BaselArea.swiss have adopted emergency aid measures in addition to those agreed by the Swiss government at national level. The cantons of Basel-Stadt, Basel-Landschaft and Jura will be supporting companies and other individuals affected to a substantial extent. The aim here is to mitigate the consequences of the coronavirus pandemic within the economic region of Basel Area.
Read More
The Basel-based pharmaceutical company Roivant Sciences wants to develop a special antibody for coronavirus patients. This is intended to help treat and prevent acute respiratory distress syndrome.
Read More
The US regulatory authority has authorized a test developed by the Basel-based pharmaceutical company Roche to detect the SARS-CoV 2 virus. Due to Roche’s work, numerous additional tests can be carried out in the USA, and for this reason Roche received the express thanks of President Trump.
Read More
The University of Basel is using computer-aided methods in its efforts to find an active substance to fight the coronavirus. A total of just under 700 million substances have been tested on a virtual basis. This has allowed interesting substances to be identified already.
Read More
Novartis and Roche feature among the hundred most innovative companies worldwide. This is from the Derwent Top 100 Global Innovators 2020 report. Roche is the only pharmaceutical company worldwide that has appeared in the list nine times.
Read More
Basel has long been one of the world’s most important locations within the pharmaceutical industry. But pharma firms are now starting to play an even bigger role in India as well. Both locations are influencing each other, as shown by the recently ended BioAsia event.
Read More
The pharmaceutical giant Roche has officially started building its new research center in Basel. Around 1,800 researchers should be able to work there by the end of 2023.
Read More
Oettinger Davidoff AG, with sales of over half a billion Swiss francs and 3,600 employees around the world, is a Swiss family owned company rooted in Basel. The company is dedicated to the business of producing, marketing, distributing and retailing premium-branded cigars, tobacco products and accessories.
Read More
The university hospital of Basel not only wants to use innovation, but also drive innovation. For this reason, the hospital established an Innovation Lab recently and launched an internal support program to help put innovation projects into practice. Driving forces behind this initiative are Jens Eckstein and Marc Strasser. DayOne asked Jens Eckstein about this push for innovation.
Read More
The FutureHealth Basel conference brought together experts, startups and those affected by digital healthcare. In addition to exploring the opportunities and challenges associated with digital healthcare, the conference also focused on strengthening the regional life sciences cluster.
Read More
Basel-based pharmaceutical Novartis is opening up its campus in Basel to external partners, including Switzerland Innovation Park Basel Area, which will establish an additional office there.
Read More
The Basel biotech company NBE-Therapeutics has successfully closed a series C financing round. The funds raised will help the company develop its leading product candidate to fight cancer.
Read More
The Czech biotech company Sotio has opened an office in the Technologiepark Basel. Sotio Biotech AG will be responsible for the company’s clinical development.
Read More
Coretag, a new dynamic biotech company, launches a radioligand platform technology for a range of therapeutic and diagnostic purposes. A radioligand is a radioactive biochemical that is used for diagnostic and therapeutic procedures or for studying the body’s receptor systems. Injected into the relevant tissue or administered into the bloodstream, the radioligand binds to its receptor on tumor cells surfaces. Coretag is determined to rapidly improve care with this platform technology.
Read More
The canton of Basel-Stadt offers one of the world’s most attractive tax burdens for companies, according to the latest BAK Taxation Index. With an effective tax burden of 11 per cent, it has ranked seventh in the world for the first time.
Read More
The Botnar Research Center for Child Health in Basel has started its research activities. The first four projects have now been selected. Together with the DayOne Accelerator from BaselArea.swiss, Basel is gradually evolving into a pediatrics hub.
Read More
The future of health is data driven. But are we ready for this to happen? This question was raised at our recent DayOne Expert Event. Answers were given by Dutch and Swiss leaders in digital health.
Read More
Diabetes patients can use an app developed by Roche to determine their blood sugar levels on the basis of two photos taken on a cell phone camera. The Basel-based pharma group has now received the CE Mark for its app, paving the way for it to be marketed throughout Europe and in other countries around the world.
Read More
The pharmaceutical company BeiGene has won a Scrip Award that recognizes contributions across the pharma sector to improving healthcare. BeiGene’s European headquarters is located in Basel.
Read More
After more than 25 years in the pharma business, Andreas Katopodis founded the biotech company Anaveon together with Professor Onur Boyman. In 2019, the startup raised 35 million CHF and will shortly complete the establishment of its new laboratory as the company progresses its products towards clinical development. With a lot of optimistic realism, Andreas takes stock.
Read More
Substantial efforts are underway in Basel to develop new areas and create space for people and companies. The efforts were welcomed by investors at the 17th Basler Investorengespräch.
Read More
Corporate tax rates in the canton of Basel-Landschaft will be cut from a maximum of 20.7 percent today to 13.45 percent in 2025. This has been stipulated by the proposed Tax Regulation 17, which was approved on Sunday.
Read More
A new initiative has been launched to support innovative SMEs and startups in the canton of Basel-Landschaft in an effort to make the region even more attractive and strengthen its ability to innovate. The initiative will offer both financial assistance and advisory services.
Read More
BaselArea.swiss manages the DayOne initiative, which is now organizing the second round of the DayOne Accelerator. The participants are Digital Health startups promoting the health of children and young people.
Read More
BaselArea.swiss is working with selected organizations and Standortförderung Baselland to support the foundation of companies in the canton of Basel-Landschaft. At the root of the partnerships is the initiative startup baselland.
Read More
The Basel-based startup Artidis is developing a medical device based on nanotechnology to help with cancer diagnoses. The spin-off from the University of Basel has now been successfully integrated in the Texas Medical Center and will therefore have access to the US market.
Read More
The canton of Jura has more than 544 hectares of building land available, a study from the Federal Institute of Technology in Zurich (ETH) has found. Local authorities have now been presented with a detailed inventory.
Read More
Basel-based biotech company Vaximm has agreed a collaboration with IT company NEC. Vaximm wants to develop personalized cancer vaccines using NEC’s artificial intelligence (AI)-based prediction system.
Read More
The Basel startup Nutrix has won a competition at the Web Summit with its business concept. It has developed a nanosensor that measures glucose levels in users’ saliva to prevent diabetes. Nutrix is supported by the Venture Mentoring program of BaselArea.swiss and has been shortlisted for the DayOne Accelerator.
Read More
Six companies won the i4Challenge: Arviem, Crevoisier, LCB Sarl, Qiio, Unitelabs and United Planet. We asked the winners to introduce themselves.
Read More
Which problem does your company aim to solve?
Read More
Which problem does your company aim to solve?
Read More
Vous êtes deux dirigeants à la tête de MultiEtch, qu’est-ce qui vous a motivé à relever ce défi entrepreneurial ?
Read More
Researchers at the Allschwil pharmaceutical company Polyphor and the University of Zurich have discovered a novel antibiotics class. It has a unique mechanism of action that allows it to target multiple bacteria.
Read More
Switzerland Innovation Park Basel Area has opened its third location. The park is now represented in Jura alongside its locations in the Cantons of Basel-Landschaft and Basel-Stadt. This represents something of a milestone for the operators BaselArea.swiss.
Read More
Start-ups established in Basel raised more than 200 million euro in investments during the first half of 2019. Basel therefore leads the way in this regard within Switzerland, and stands in eighth place across Europe, as revealed by a new EY study.
Read More
Basel-based biopharmaceutical Versameb has raised 6.4 million Swiss francs in a Seed C financing round and will put the funds towards expanding its technology platform. Versameb was supported by the healthcare accelerator program BaseLaunch of BaselArea.swiss in 2017/18.
Read More
Basel-based start-up Tide Ocean turns ocean plastic waste into new products such as watches. It has now won a German design and technology award for its contribution to the circular economy.
Read More
Kindoh, a daily consumer product brand, is moving its headquarters to Basel. The location promotion organization BaselArea.swiss supported the company’s relocation from the start.
Read More
The Swiss National Bank is working on a fintech project with the SIX stock exchange to explore technological options to make digital central bank money available. The study is being conducted at the new Swiss BIS Innovation Hub Center in Basel.
Read More
Novartis has selected Microsoft as its new strategic artificial intelligence (AI) and data science partner. With the collaboration, the Basel pharmaceutical giant aims to bolster its AI capacities and promote the development of transformative medicines.
Read More
As part of the competition i4Challenge, BaselArea.swiss offers six start-ups and SMEs from Switzerland, Alsace or Baden-Württemberg comprehensive support, a platform for the implementation of their activities and, among other things, the opportunity to participate in the Trinational trade fair Industrie 4.0 (BE4.0) in Mulhouse. A high-caliber jury of independent experts has evaluated and benchmarked the various applicants very precisely.
Read More
T3 Pharma, a Basel-based biotech company, has closed its second financing round and raised in excess of 12 million Swiss francs in the process. The company’s management has now also been strengthened as it seeks to bring its immuno-oncological product candidates into the clinical development phase.
Read More
The Switzerland Innovation Park Basel Area offers an insight into its activities. The future home of the Park will be presented in a new showroom. Scientists from the University of Basel will also be presenting their latest developments here.
Read More
One month before the official opening, the Jura site of the Switzerland Innovation Park Basel Area welcomes its first tenant: NextDay.Vision, a start-up from the Jura, opens its office at the park. The company was also one of the winners of the i4Challenge 2018.
Read More
Work on the construction of the GRID complex for innovation and commerce has begun on the BaseLink site in Allschwil BL. By mid-2022, the Switzerland Innovation Park Basel Area will be operating from the new site as its anchor tenant.
Read More
The Switzerland Innovation Park Basel Area will be opening its Jura site on 25 October. Claude-Henri Schaller, Director of the Office for the Economy and Labour and Vice President of Switzerland Innovation Park Basel Area AG, is convinced that the Innovation Park can make a major contribution to the diversification of industry in the Jura and will create stronger ties between industry and research.
Read More
Twenty-two panellists and speakers, among them 3 patients and digital health futurist Maneesh Juneja, 30 project champions and their mentors, 40 volunteers and 450 participants and Arcondis as conference Partner — this was the DayOne Conference which took place on September 9 at the FHNW in Muttenz.
Read More
Indigo Agriculture is expanding to Europe and has opened headquarters in Basel to this end. The U.S. company offers pioneering technologies for the agricultural sector. BaselArea.swiss supported Indigo in relocating to Basel.
Read More
C’est un programme plein d’activités qui vous attend au Switzerland Innovation Park Basel Area, site du Jura, sur le Campus technologique innodel à Courroux depuis cette rentrée.
Read More
Growcer AG is currently building a machine-operated vegetable farm in Basel. Robots sow, water and fertilize the vegetables, which are then harvested by humans. The concept promises to drastically reduce carbon emissions, water and fertilizer.
Read More
The top 100 startups of Switzerland have been revealed. In Venturelab’s Top 100, the Basel region performs particularly well in the biotech sector, while almost all the Basel companies named have benefited directly or indirectly from BaselArea.swiss.
Read More
The canton of Basel-Stadt is one of the three largest Swiss technology clusters for advanced digitalization technologies, as the new Digitalization Atlas has revealed. It is especially strong in artificial intelligence, with Roche, in particular, filing many patents in this area.
Read More
Switzerland often receives awards for its innovative strength. Life sciences have generally played a huge part in this acclaim. The BaseLaunch accelerator operated by BaselArea.swiss is a major reason for innovation, a media report has found.
Read More
Versant Ventures has a strong history in building successful companies such as Therachon, Black Diamond or CRISPR Therapeutics. We talked to Alex Mayweg, partner at Versant Ventures in Basel, about the beauty of Versant Ventures discovery engine Ridgeline Therapeutics, translating science into successful drug development programs and the future of drug discovery.
Read More
Nina Khanna Gremmelmaier has been awarded this year’s prize for science of the City of Basel. The University Hospital Basel doctor was honored for her work into combating resistance to antibiotics.
Read More
The US-based company Adobe is developing a technology in Basel that will make it possible to display content on screens more quickly. Basel is a central R&D location for the American software provider, says Christoph Kull, head of Central Europe at Adobe.
Read More
DayOne, a BaselArea.swiss initiative, is creating a world-leading healthcare innovation hub based on the strengths of the Basel region. A further important partner has joined to help achieve this goal.
Read More
Synendos Therapeutics AG with headquarters in Allschwil is benefiting from the financial support for which small and medium-sized enterprises can apply within the framework of Horizon 2020, a program launched by the EU. The pharma company is also supported by the start-up accelerator BaseLaunch.
Read More
The DayOne Lab at the Technologiepark Basel provides a new and unique place for collaboration, creation and innovation: The lab is dedicated to startups, entrepreneurs and intrapreneurs and innovators in the realm of digital health who are interested in interacting with the residents at Technologiepark and keen to play an active role in strengthening the ecosystem in the Basel region.
Read More
Basel-based chemicals and pharmaceuticals company Lonza acquires facility for sterile drug manufacturing from Novartis. With the new production facility in Stein AG Lonza will extend its service offering, as well as taking on the existing employees and providing investment in Basel.
Read More
Tomasz Sablinski, Founder and CEO of Transparency Life Sciences raised the crunch question of the evening: Which industry is lagging behind the most in terms of digitization? Right, it is the healthcare industry! But who would have expected the usual lamentation of why this is the case; blaming regulatory constraints, scarce innovation culture, or unachievable technology barriers proved wrong. The appetite for change and finding new ways of doing things was too strong among Basel’s Healthcare innovators at the DayOne Expert Session on “Next Generation Digital Trials”.
Read More
The Swiss Tropical and Public Health institute (Swiss TPH) has broken ground on the new building for its headquarters in Allschwil. Set for completion by the end of 2021, the new building will offer nearly 900 workplaces, laboratory spaces as well as teaching facilities.
Read More
A competence center for Industry 4.0 is being created on the former site of ABB. Private investors have contributed around half a million Swiss francs to the project. The foundation stone has now been officially laid.
Read More
Venez innover avec nous ! Tel est le slogan pour les ateliers et séminaires qui seront organisés dans le Switzerland Innovation Park Basel Area du Jura pour les entreprises jurassiennes. Un programme alléchant qui traitera autant de sujets de diversification que de thématiques telles que l’intelligence artificielle ou le design thinking. A coup sûr, ce sont des sujets qui vous intéresseront.
Read More
The Switzerland Innovation Park Basel Area already has two sites, in Allschwil and Basel, and will soon add a third in the Jura. It will be located on the Innodel campus in the municipality of Courroux, between Delémont and Courrendlin. Work is ongoing at the Jura site, which is set to officially open on 25 October.
Read More
Healthcare accelerators recently came under the spotlight of technology platform Technorely. Its list of eight of the leading accelerators features BaselArea.swiss-operated BaseLaunch as one of only two outside North America.
Read More
T3 Pharmaceuticals is among the winners of this year’s W.A. de Vigier Award. The spin-off from the University of Basel is developing a targeted cancer therapy using bacteria.
Read More
Healthcare Accelerator BaseLaunch, which is operated by the location promotion organization BaselArea.swiss, is among the leading accelerators of its kind in Europe, according to a media report. BaseLaunch is the only Swiss Healthcare Accelerator to feature.
Read More
U.S. pharmaceutical company Pfizer is acquiring Basel biotech Therachon for US$ 340 million. Additional payments of US$ 470 million may also be received on the achievement of key milestones. Therachon has developed a drug for the treatment of a form of short-limbed dwarfism.
Read More
According to an article in the journal “Nature”, Switzerland is the European leader with its biotech start-up ecosystem. Based on population size, Switzerland ranks in first place for both venture capital and patent and research output.
Read More
Over the space of 150 years, a butcher’s in Basel has grown into an international food company, with the Bell Food Group now employing more than 12,000 people in 15 countries. Markus Ettlin, Head of Industry 4.0/Automation at the Bell Food Group, provides an update on the company’s current Industry 4.0 projects, the limits of automation, and innovations in the food sector.
Read More
Cerdia’s history starts with Rhodia Acetow more than 100 years ago: The company was founded in 1912 in the Rhone valley in France. Its specialty were polyester and nylon textiles. Later, Rhodia Acetow developed huge business opportunities in producing cigarette filter tow and cellulose acetate. In 2018, the company opened a new chapter in their books: The international headquarters were moved from Freiburg i.B., Germany to Basel. The new stand-alone entity in Basel was rebranded Cerdia in March 2019. Today, Cerdia has an annual turnover of more than 600 million Swiss francs. 1300 employees work for the company with hubs in France, Singapore, the US, Brazil and Russia.
Read More
The Basel-based biotech company Alentis Therapeutics AG has successfully concluded a CHF 12.5 million Series A financing co-lead by BioMedPartners and BB Pureos Bioventures and joined by BPI France, Schröder Adveq and the HTGF. Alentis develops therapeutics in advanced liver disease and cancer.
Read More
Launching a biotech is a daunting endeavor. Resources – both human and capital - are scarce and have to be fully dedicated to advancing science and building the company. Unfortunately, a significant amount of the initial capital, time and energy are often spent on setting up lab infrastructure: This includes negotiations with suppliers, wait times of months until equipment arrives, getting all the necessary permits, taking on the financial risk of signing long-term lease agreements, and much more.
Read More
Lyfegen, an IT company specializing in healthcare from Basel, has raised 750,000 Swiss francs in a seed financing round. The startup has developed a software solution to overcome technical hurdles in value-based healthcare.
Read More
Novartis completed the spin-off of the Alcon eye care devices business through a dividend-in-kind distribution. The Basel pharma giant reports it is now positioned for sustained growth and announced the launch of potential blockbusters.
Read More
Energy company Innolith has developed a new type of battery that gives electric vehicles a range of 1,000km. The innovation has now been registered for a patent and will be launched on the market via an initial pilot production.
Read More
Closing a deal is more art than science. This is especially true in the biopharma industry where investments and partnerships are key elements to success. That is why, together with JLABS, BaseLaunch organized a panel of seasoned deal makers to discuss the nuts and bolts of the partnership process.
Read More
A new master’s degree at the FHNW University of Applied Sciences and Arts Northwestern Switzerland aims to prepare the next generation of professionals in the life sciences industries: Students in “Medical Informatics” are trained to apply the latest technologies during projects for the medical and pharmaceutical industries. Professor Enkelejda Miho from the Institute for Medical and Analytical Technologies at FHNW is confident that the combination of life sciences, informatics and business brings forward a desired new profile of professionals.
Read More
Swiss Prime Site is about to create additional office and laboratory space for 1,700 new jobs at Stücki Park in Basel. The chemical specialists Lonza will rent space to hire an additional 250 specialists from 2020.
Read More
The efforts of BaselArea.swiss proved extremely successful in 2018. 33 companies – seven more than in the previous year – were persuaded to move to the Basel economic region. 16 companies arrived from Europe, nine of which came from Germany. BaselArea.swiss also supported six Swiss companies in the search for a suitable business location in the Basel region. Of the newly arrived companies, 19 operate in the life sciences and chemicals sectors.
Read More
Three innovative healthcare startups participate in the first round of the DayOne Accelerator. Faraz Oloumi from Aurteen, Chang Yun from Noul and Christian Vogler and Leo Gschwind from Advancience are examples of how far conviction can get you.
Read More
The biopharmaceutical company SunRegen Healthcare develops a therapy for neurodegenerative eye diseases like Optic Atrophy. The two co-founders and managers Dr. Yuhong Dong and Mr. David Guan moved their young startup to the Switzerland Innovation Park Basel Area in Allschwil in January 2019.
Read More
The Canton of Basel-Stadt has lowered its tax rates on income, corporate income and capital retroactively to 1 January 2019. Its corporate taxes will from now on be among the lowest in Switzerland and in Europe, making Basel even more attractive as a business location.
Read More
Humanity is growing older. According to the UN the number of people in the world aged 60 years or over is projected to double to 2.1 billion by 2050. In developed countries, more than one third of the population will be over 60 by this time. The number of people over 80 will increase even faster to 434 million from 125 million in 2017. Meanwhile the working age population, who are needed to pay or provide support for the elderly, will only increase by about 25 percent over the same time.
Read More
Anaveon, an immuno-oncology biotech, has successfully concluded a Series A financing round led by Syncona, a UK Life Sciences fund, and joined by the Novartis Venture Fund. The company was founded with financing from BaseLaunch, the healthcare accelerator of BaselArea.swiss in December 2017 and in 2018 also raised additional seed money from the UZH Life Sciences Fund.
Read More
BaseLaunch supports carefully selected ventures in two phases. After an intense pressure test period, four projects were selected for Phase II of our second year. They now have the opportunity to further advance their breakthrough healthcare innovation and secure further investment.
Read More
With the ambitious goal of being a zero-emission building, Basel’s youngest skyscraper Grosspeter Tower was constructed to cover its own power requirements. Already during the construction phase, this impressive 78 meter office building by Burckhardt+Partner was awarded numerous prizes for its unique sustainable design and its building fabric. In particular, the façade, which is half windows, half integrated photovoltaic system - the first of its kind in Europe – make the building an efficient powerhouse.
Read More
One of the pillars of BaselArea.swiss’ DayOne (www.DayOne.swiss) strategy is to drive Catalyst projects – collaborative approaches to bottleneck issues in Healthcare innovation. These are “wicked problems” that can only be solved collaboratively. Therefore, Catalyst Projects focus on challenges to which it is difficult to find solutions within the current industry structures.
Read More
Désirée Mettraux has been the CEO of Creadi since 2016. The Pax spin-off has developed the Simpego online insurance platform. The insurance expert is confident that the industry will profit if it opens itself up to partners. The aim is to make insurance fun.
Read More
To develop a scientific discovery into a life-changing drug or technology, it takes experts from various fields. The Basel region provides all of the crucial ingredients needed to foster innovation. BaseLaunch and Labiotech.eu created an infographic that shows all the important players in Basel’s Biotech and Pharma ecosystem.
Read More
Rencontre au cœur des champs d’un petit village jurassien, entre traditions rurales voisines et haute précision mécanique. Entretien avec le co-directeur du Groupe, Monsieur Christophe Rérat.
Read More
Resistell has closed on oversubscribed seed financing round. The Basel-based startup is developing an antibiotic susceptibility test that is much faster than conventional tests.
Read More
Antibiotic resistance is fatal: If antibiotics have no effect, simple infections become deadly. According to the World Health Organization, an estimated 700,000 people die each year worldwide from bacterial infections. Additionally, research on new antibiotics had been drastically reduced in the last decades. However, companies in the Basel region such as Basliea, BioVersys, Idorsia, Polyphor and Roche as well as the University of Basel and the FHNW are pursuing the field of antimicrobial resistance (AMR).
Read More
Marco Cuomo and Daniel Fritz from Novartis got engaged in blockchain two years ago. Today, their aim is set high: With other pharma companies under the Innovative Medicines Initiative, they formed a “Blockchain Enabled Healthcare” program, due to kick off in 2019. The program that they presented at the Blockchain Leadership Summit in Basel – Switzerland’s largest conference in this field - wants no less than to define how blockchain is applied in healthcare.
Read More
DayOne and BaselArea.swiss are happy to announce the winners of the first DayOne Accelerator supported by Fondation Botnar:
Read More
Expats find Basel to be the best city in Switzerland, according to a study published by InterNations. Six Swiss cities were analyzed as part of its latest Expat City Ranking.
Read More
The energy services provider GETEC is acquiring Infrapark Baselland AG and its activities from the chemicals company Clariant. GETEC also intends to acquire Novartis’s facilities in the neighbouring Schweizerhalle, thus boosting the site’s attractiveness.
Read More
The Basel-based pharmaceutical company Roivant Sciences has raised USD 200 million in a funding round. As a result, the company is now valued at an estimated USD 7 billion.
Read More
Next year, chemical company Van Baerle will move from Münchenstein in the canton of Basellandschaft to the Schweizerhalle industrial location. Owner and CEO Daniel Schenk summarized the advantages of the new location in an interview.
Read More
Rencontre avec Georges HUMARD, le co-propriétaire et CEO de HUMARD Automation SA à Delémont.
Read More
BaselArea.swiss invited startups and Industry 4.0 projects to participate in the first Industry 4.0 Challenge. A jury from the industry chose three finalists: Philippe Kapfer with NextDay.Vision, Roy Chikballapur with MachIQ and Dominik Trost with holo|one. Learn more about their contributions and visions in the interview. You can meet the entrepreneurs at the Salon Industries du Futur Mulhouse on 20 and 21 November 2018.
Read More
100’000 geflüchtete Menschen leben derzeit in der Schweiz, darunter viele High Potentials mit IT-Kenntnissen. Gleichzeitig herrscht in der Branche Fachkräftemangel. Diese Kombination hat Potenzial: Der Verein Powercoders hat sich zum Ziel gesetzt, IT-Fachleute und Unternehmen zusammenzubringen. Zu diesem Zweck werden aus einer Gruppe von über 100 Bewerberinnen und Bewerbern die 20 bestqualifizierten herausgesucht. Sie durchlaufen anschliessend ein dreimonatiges intensives Training, die Coding Academy. Hier erhalten sie technisch den letzten Schliff und werden gleichzeitig auf die kulturellen Anforderungen an das Arbeiten in der Schweiz vorbereitet. Anschliessend absolvieren sie ein sechs- bis zwölfmonatiges Praktikum bei einem Schweizer Unternehmen, aus dem im besten Fall eine Festanstellung wird.
Read More
SOLO Swiss in Porrentruy in the canton of Jura has been making industrial furnaces for heat-treating metals since 1924. The family company with a global presence is developing against the backdrop of Industry 4.0 and is struggling to find the qualified workforce which is indispensable for what it does amid the effects of the strong franc and what are sometimes restrictive administrative regulations. Interview with Anne-Sophie Spérison, President and CEO.
Read More
The semester has got off to a successful start at FHNW University of Applied Sciences and Arts Northwestern Switzerland’s new Campus Muttenz. With 4,000 students and 800 employees, the campus comprises five schools.
Read More
BeiGene, Ltd., a global commercial-stage biopharmaceutical company, has established a regional headquarters in Basel. BaselArea.swiss assisted BeiGene in evaluating and establishing the new site.
Read More
The BaseLaunch Accelerator, managed and operated by BaselArea.swiss, started on 14 September 2018 with ten projects entering Phase I. Over the next few months, the project teams will work with experts and advisers from various fields to define the next key R&D milestones to de-risk the science, to refine their business case, and to develop the company further.
Read More
DayOne has a history of changing and growing each year. This year the DayOne Conference took place on 11 September, and it kept its promise and it felt like several gears were being shifted. This has to do with three factors: world relevance, innovation community engagement and patient dialogue outreach.
Read More
M. Karim Drici, directeur des manufactures Cartier Horlogerie et M. Jacques Gerber, Ministre de l’économie et de la santé de la république et canton du Jura ont coupé le ruban lors de l’inauguration de la nouvelle manufacture Cartier à Glovelier. Un bâtiment tout neuf que les 120 employés ont intégré quelques mois plus tôt : un bâtiment flexible, respectueux de l’environnement et améliorant le confort des salariées.
Read More
Startups in the Basel region have a new home: The 2017 established Hubbasel Association is now an official member of the global Impact Hub family. All Impact Hub candidates need to go through a challenging process that can take years, with the official head organization supporting and evaluating the candidates.
Read More
Basel has the biggest economic potential in Europe, according to a new study from BAK Economics. The city on the bend of the Rhine ranked particularly well for competitiveness, while Geneva and Zurich also came in the top five.
Read More
The serial entrepreneur Neil Goldsmith is drawn to new ventures. We spoke to him about discovering talent suitable for start-ups and about his current involvement with BaseLaunch.
Read More
Last winter, Julia got a cough and a headache. For the third time she went to her physician, who sent her home with painkillers, thinking that it was, after all, just another case of flu. But what if Julia was different from the other flu-stricken patients that the doctor had seen previously? What if her symptoms were those of a rare cancer?
Read More
Basel is among the European biotech hubs with the most exciting companies as named by labiotech.eu. The industry platform highlighted businesses including Actelion and Polyphor.
Read More
The physician and pharmacologist Nicole Onetto is a member of the Board of Directors at the Basilea Pharmaceutica AG. In the Interview that was featured in Basilea’s annual report she talks about current challenges in oncology.
Read More
In 2016, Roivant Sciences established their global headquarters in Basel. Roivant founder and CEO Vivek Ramaswamy talked to us about his fast growing company, his priorities for the company and about the role that Roivant aims to play in the Basel life sciences ecosystem.
Read More
Seeking brilliant project ideas that, combined with digital technologies, healthcare expertise and entrepreneurial spirit, will help solve the health challenges and unmet needs of young people. Selected projects will receive up to 70,000 CHF in non-dilutive funding.
Read More
Polyneuron Pharmaceuticals has successfully raised over 3 million Swiss francs in a financing round. The Basel-based pharmaceutical company is developing an active substance for the treatment of the autoimmune disease anti-MAG neuropathy, among others.
Read More
A l’heure où l’industrie 4.0 envahit le quotidien des éditions spécialisées, des PME et industries, il existe encore des sociétés pour qui le facteur humain et ses compétences sont d’une valeur capitale pour la pérennisation de leur offre. Rencontre avec Olivier Haegeli, Co-Directeur de Willemin-Macodel SA à Delémont, au Jura.
Read More
Basel among the ten cities with the highest quality of living in the world, according to a survey from the consultancy group Mercer. The city ranking can help companies decide where to open a new office.
Read More
Six of the BaseLaunch startups recently started Phase II. They received either grants up to 250,000 Swiss francs or gained free of charge access to BaseLaunch laboratory and office space at the Switzerland Innovation Park Basel Area. Hear what the startups, the BaseLaunch team and selection committee members experienced in the first year. Find out more about what makes BaseLaunch unique.
Read More
Basel-based venture capitalist firm BioMedPartners has closed its new venture capital fund BioMedInvest III at 100 million Swiss francs. The fund will help drive growth in the Swiss life science cluster by investing in private early-to-mid-stage companies.
Read More
The world renowned surgeon from Basel, Beat Hintermann, has successfully implanted ankle prosthesis of his own design in five patients in Liestal. Hintermann products are distributed by the U.S. company DT MedTech LLC.
Read More
BaseLaunch has officially started Phase II of its accelerator program, and four startups are receiving grants ranging from 120,000 to 250,000 Swiss francs. This non-dilutive funding will help them to reach key value inflection milestones to advance their scientific hypothesis and further build their ventures, while learning and benefiting from the Basel life sciences ecosystem. Furthermore, two startups will gain access to the ready-to-use laboratory and office space, both free of charge, at the Switzerland Innovation Park Basel Area.
Read More
Roivant becomes the fifth healthcare partner of BaselArea.swiss accelerator program joining Johnson & Johnson Innovation, Novartis Venture Fund, Pfizer and Roche.
Read More
Impact Hubs are a real success story. Founded in 2005 in London, there are now over 100 Impact Hubs around the world with more than 15,000 members. Following the lead from Bern, Zurich, Geneva and Lausanne, Basel will be the next Impact Hub in Switzerland. The force behind the movement is Hubbasel, an association founded by entrepreneur André Moeri, sustainability expert Connie Low and lawyer Hanna Byland. We wanted to know why an Impact Hub is more than just a coworking space and how entrepreneurs as well as investors and companies benefit from them, so we talked with Hanna Byland to shed some light for us.
Read More
The Basel pharmaceutical companies Roche and Novartis are among the 40 most valuable companies in the world, according to an EY study. American tech firms top the list.
Read More
The Basel-based pharmaceutical company Novartis has released positive data on the long-term efficacy of its medication Cosentyx, which is used for hard-to-treat types of psoriasis.
Read More
The number of jobs in the pharmaceutical industry is on a steady rise – and other industries are benefiting from the success of the pharmaceutical companies. According to a new study from BAK Economics, the pharmaceutical industry is the most important driver of growth in Switzerland as a centre of industry.
Read More
On September 15th 2017, the first Swiss-Chinese Life Sciences Forum took place at Roche in Basel. The event focused on the two key topics of “Challenges, Responses and Opportunities in the Chinese Health Sector” and “Digital health in China”.
Read More
The BaseLaunch Healthcare Accelerator program from BaselArea.swiss started on September 14. Over 100 applications were received from more than 30 countries, and the selection committee has selected 13 projects to go on to Phase I. Now, the project teams will work with industry experts to further develop their business case over the next three months.
Read More
“Faster but with Respect and Trust“ - these were the final words from Effy Vayena at the DayOne Experts event at EMBO Basel life. The message was to encourage the healthcare and life science communities to move faster to make the large scale use of patient data a reality whilst dealing with this data with enough respect for the individual to deserve the trust the patient has in the system.
Read More
Halozyme, a U.S. biotechnology company developing novel oncology and drug-delivery therapies, has established their European headquarters office in Basel, Switzerland.
Read More
Ulf Claesson is a "serial entrepreneur". During the past 25 years, he has set up companies that have gone on to become firmly established in the market. In 2012, he joined Clinerion as CEO and shareholder. Since then, the company has positioned itself in the medical data field and recently entered into a partnership with British company Cisiv. Clinerion's software helps recruit patients for clinical trials run by major pharmaceutical companies – in real time. But the competition never sleeps. A growing number of competitors is now appearing, especially in the USA where there is no shortage of risk capital. In this interview for the Innovation Report, Claesson explains how the Basel-based healthtech company plans to maintain its leadership position.
Read More
Wo der 3D-Druck bereits heute standardmässig eingesetzt wird, in welche Richtungen sich die Technik entwickelt und welche rechtlichen Fragen dadurch auftauchen, zeigte das Symposium «3D Printing for Life Sciences» an der Hochschule für Life Sciences in Muttenz auf. BaselArea.swiss führte die Veranstaltung mit Unterstützung des Universitätsspitals Basel und des Kantonsspitals Baselland durch. Falko Schlottig, Direktor der Hochschule für Life Sciences, und Sébastien Meunier von BaselArea.swiss begrüssten über 200 Teilnehmerinnen und Teilnehmer in der Aula.
Read More
Wer Laborgeräte oder eine mikrobiologische Sicherheitswerksbank benötigt, muss bei Neuanschaffungen tief in die Tasche greifen. Werden hingegen Laborgeräte nicht mehr benötigt, kostet die Entsorgung der Ausrüstung oder der Verkauf auf dem Gebrauchtwarenmarkt Zeit und Geld.
Read More
More than 100 projects from Switzerland and abroad competed for a place in the BaselArea.swiss accelerator program for healthcare startups.
Read More
Die ausserordentliche Generalversammlung vom 29. Juni 2017 wählte Gilbert Achermann einstimmig in den Verwaltungsrat der Switzerland Innovation Park Basel Area AG und bestimmte ihn zum Präsidenten des Verwaltungsrates. Mit Gilbert Achermann, Verwaltungsratspräsident Straumann Holding AG, gewinnt Switzerland Innovation Park Basel Area eine starke Führungsperson aus der Industrie mit breiter Erfahrung in der Medizinaltechnik.
Read More
The German life sciences company Bayer wants to continue to grow in Basel, as company representatives announced in a press conference. Bayer settled in Basel in 2005. Since then, the number of employees has risen from 120 to 750. For the coming years, the group expects 100 additional employees per year. The workforce includes people from 60 nations.
Read More
How can Switzerland and the Basel region maintain their international leadership role in life sciences? As part of the Biotech and Digitization Day, Federal Councillor Johann Schneider-Ammann visited the Basel region to discuss current trends and challenges with a high-ranking delegation from politics, business, research and start-ups.
Read More
In April, Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products opened a facility in Basel, Switzerland. The new site will serve as a European headquarters for the company with administration offices and other areas that include research and development, purchasing, sales, and distribution. Bio-Rad was founded in 1952 and is based in Hercules, California, and has offices and facilities around the world. In 2017, embarking on its 65th year of operation, Bio-Rad’s global network of over 8,250 employees and operations are helping people live longer, healthier lives.
Read More
It all began with research resources that were a quarter of a century old. Simon Ittig and his colleagues at the Biozentrum of the University of Basel turned these into a research project – and eventually a start-up. T3 Pharmaceuticals develops new therapies to treat solid tumours.
Read More
The new accelerator for healthcare ventures, BaseLaunch, wants to link the best start-ups to the Basel region – and in doing so, provide impulses for major players. The project will consistently focus on quality and the concentrated know-how in the region, says Managing Director Alethia de Léon.
Read More
“If we invest billions in university research, then this remains an abortive effort if we do not make sure at the same time that these scientific achievements also result in value added – and in Switzerland, not elsewhere,” said Christoph Klöpper, CEO of BaselArea.swiss, on the launch of BaseLaunch, an accelerator programme for healthcare ventures initiated and operated by the innovation promotion and economic development of Region Basel.
Read More
Basel is among the top ten cities with the highest quality of living in the world, according to the latest Mercer Quality of Living ranking. 2017 marks the first year that Basel was included in the ranking.
Read More
BaseLaunch, an accelerator initiative launched and run by the location promotion organisation BaselArea.swiss, is a new partner of the start-up accelerator Kickstart. Life sciences start-ups will be promoted through a second Kickstart programme.
Read More
Idemitsu Kosan is a Japanese petroleum company, but it also develops and manufactures electronic materials. The company is now opening a research and development centre for organic light-emitting diodes in Basel, its first outside of Japan.
Read More
Basel – Novartis’ Cosentyx has proven highly effective against psoriasis. The skin condition can cause psychological problems for many patients and can be very difficult to treat.
Read More
Thomas Fischer ist Chief Operating Officer bei der Biotechnologiefirma AVA Biochem in Muttenz.
Read More
Thomas Fischer is Chief Operating Officer with the biotechnology company AVA Biochem in Muttenz.
Read More
Philadelphia-based company Axalta Coating Systems, a leading global supplier of liquid and powder coatings is establishing its European business activities in the city of Basel, Switzerland.
Read More
BaselArea.swiss Economic Promotion is pleased to announce that Ultragenyx, a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases based in the San Francisco Bay Area, California, is opening their European headquarters in the city of Basel, Switzerland. Stefano Portolano, M.D., has been appointed Senior Vice President and head of Ultragenyx Europe. In this role, Dr. Portolano will be responsible for building and leading the Ultragenyx commercialization efforts across Europe and developing the company's European organization.
Read More
Basel region. The entrepreneur has a large network of contacts that allows him to establish access not only to investors, but also to know-how and talents.
Read More
Hans-Florian Zeilhofer is a surgeon, innovator, scientist and entrepreneur. He has performed pioneering work in many fields of reconstructive facial surgery. Always driven by the goal of improving the situation for his patients, Zeilhofer is constantly initiating new projects that meet with international acclaim – as also with his latest project, Miracle, which his team will present at the Lift Basel Conference 2015.
Read More
«I don’t have any lessons to impart, just the opportunity to share my experience.» It was with these words that Pascal Bourquard introduced his speech at the event entitled «Out-of-the-box with Pascal Bourquard – insights about entrepreneurship».
Read More
© 2020 BaselArea | Terms & conditions | Privacy policy
